KR19980034291A - Skin whitening composition containing galloylgalactose - Google Patents

Skin whitening composition containing galloylgalactose Download PDF

Info

Publication number
KR19980034291A
KR19980034291A KR1019960052294A KR19960052294A KR19980034291A KR 19980034291 A KR19980034291 A KR 19980034291A KR 1019960052294 A KR1019960052294 A KR 1019960052294A KR 19960052294 A KR19960052294 A KR 19960052294A KR 19980034291 A KR19980034291 A KR 19980034291A
Authority
KR
South Korea
Prior art keywords
galactose
galloyl
tri
skin whitening
composition
Prior art date
Application number
KR1019960052294A
Other languages
Korean (ko)
Inventor
이상화
이용규
이천구
강세훈
이승호
Original Assignee
성재갑
주식회사 엘지화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 성재갑, 주식회사 엘지화학 filed Critical 성재갑
Priority to KR1019960052294A priority Critical patent/KR19980034291A/en
Publication of KR19980034291A publication Critical patent/KR19980034291A/en

Links

Landscapes

  • Cosmetics (AREA)

Abstract

본 발명은 기미나 주근깨 개선 및 피부 미백제로서 갈로일갈락토오스(galloyl galactose)를 함유하는 피부 미백용 조성물에 관한 것이다.The present invention relates to a composition for skin whitening containing galloyl galactose as an anti-finite freckles and a skin whitening agent.

Description

[발명의 명칭][Name of invention]

갈로일갈락토오스를 함유하는 피부 미백용 조성물Skin whitening composition containing galloylgalactose

[발명의 상세한 설명]Detailed description of the invention

[발명의 목적][Purpose of invention]

본 발명은 기미나 주근깨 개선 및 피부 미백제로서 갈로일갈락토오스(galloyl galactose)를 함유하는 피부 미백용 조성물에 관한 것이다.The present invention relates to a composition for skin whitening containing galloyl galactose as an anti-finite freckles and a skin whitening agent.

[발명이 속하는 기술분야 및 그 분야의 종래기술][Technical Field to which the Invention belongs and Prior Art in the Field]

희고 고운 피부를 갖고자 하는 것은 모든 사람의 한결같은 소망이다. 사람의 피부색은 피부내 멜라닌(melanin)의 농도와 분포에 따라 유전적으로 결정되나, 태양 자외선이나 피로, 스트레스 같은 환경적 또는 생리적 조건에 의해서도 영향을 받는다. 멜라닌은 아미노산의 일종인 타이로신(tyrosine)에 타이로시네이즈(tyrosinase)라는 효소가 작용하여 도파(DOPA), 도파퀴논(dopaquinone)으로 바뀐 후 비효소적인 산화반응을 거쳐 만들어진다. 타이로시네이즈가 멜라닌 합성과정에서 이렇듯 중요한 역할을 하기에 종래 하이드로퀴논이나 아스콜빈산, 코지산(kojic acid), 글루타치온 같은 타이로시네이즈에 저해 활성을 갖는 물질을 연고나 화장료에 배합함으로써, 피부미백이나 기미, 주근깨 개선의 목적에 사용되어 왔으나, 피부에 자극성을 유발하거나 제품 안정성이 좋지 못하여 사용이 제한되고, 또 그 효과도 미약한 단점이 있다.It is everyone's constant desire to have white, fair skin. Human skin color is genetically determined by the concentration and distribution of melanin in the skin, but is also influenced by environmental or physiological conditions such as solar ultraviolet light, fatigue and stress. Melanin is a type of amino acid tyrosine (tyrosine) enzyme called tyrosinase (tyrosinase) acts to convert to dopa (DOPA), dopaquinone (dopaquinone) is produced through a non-enzymatic oxidation reaction. Because tyrosinase plays such an important role in melanin synthesis process, by combining substances having inhibitory activity against tyrosinase, such as hydroquinone, ascolic acid, kojic acid, and glutathione, in ointments or cosmetics, Although it has been used for the purpose of skin whitening, blemishes, and freckles, the use is limited because it causes irritation to skin or poor product stability, and the effect is also weak.

[발명이 이루고자 하는 기술적 과제][Technical problem to be achieved]

본 발명자들은 이러한 문제점들을 해결하고 보다 우수한 미백물질을 개발하고자 수많은 연구와 실험을 거듭한 결과, 이미 그 안전성이 입증되어 있는 천연물들 중에서 미백 효과가 우수한 물질을 탐색하던 중 천연물로부터 분리한 갈로일갈락토오스가 우수한 타이로시네이즈의 저해작용을 나타낼 뿐만 아니라 배양된 세포를 이용한 멜라닌 생성억제 실험과 사람에 대한 실험에서 그 효과가 있음을 밝혀내고 본 발명을 완성하게 되었다.The present inventors have conducted numerous studies and experiments to solve these problems and to develop better whitening materials. As a result, galloyl galactose isolated from natural products while searching for a material having excellent whitening effect among natural products that have already been proved in safety. In addition to showing excellent inhibitory effect of tyrosinase, it was found that the melanin production inhibitory experiments using cultured cells and experiments on humans have completed the present invention.

[발명의 구성 및 작용][Configuration and Function of Invention]

본 발명은 갈로일갈락토오스(galloyl galactose)를 건조중량에 대하여 0.001 내지 20 중량% 함유함을 특징으로 하는 피부미백용 조성물에 관한 것이다.The present invention relates to a composition for skin whitening, characterized in that it contains 0.001 to 20% by weight of galloyl galactose with respect to dry weight.

본 발명에서 사용되는 갈로일 갈락토오스는 1-o-갈로일-β-D-갈락토오스, 2-o-갈로일-D-갈락토오스, 3-o-갈로일-D-갈락토오스, 4-o-갈로일-D-갈락토오스, 6-o-갈로일-D-갈락토오스, 1,2-디-o-갈로일-β-D-갈락토오스, 1,3-디-o-갈로일-β-D-갈락토오스, 1,4-디-o-갈로일-β-D-갈락토오스, 1,6-디-o-갈로일-β-D-갈락토오스, 2,3-디-o-갈로일-D-갈락토오스, 2,4-디-o-갈로일-D-갈락토오스, 2,6-디-o-갈로일-D-갈락토오스, 3,4-디-o-갈로일-D-갈락토오스, 3,6-디-o-갈로일-D-갈락토오스, 4,6-디-o-갈로일-D-갈락토오스, 1,2,3-트리-o-갈로일-β-D-갈락토오스, 1,2,4-트리-o-갈로일-β-D-갈락토오스, 1,2,6-트리-o-갈로일-β-D-갈락토오스, 1,3,4-트리-o-갈로일-β-D-갈락토오스, 1,3,6-트리-o-갈로일-β-D-갈락토오스, 1,4,6-트리-o-갈로일-β-D-갈락토오스, 2,3,4-트리-o-갈로일-D-갈락토오스, 2,3,6-트리-o-갈로일-D-갈락토오스, 2,4,6-트리-o-갈로일-D-갈락토오스, 3,4,6-트리-o-갈로일-D-갈락토오스, 1,2,3,4-테트라-o-갈로일-β-D-갈락토오스, 1,2,3,6-테트라-o-갈로일-β-D-갈락토오스, 1,2,4,6-테트라-o-갈로일-β-D-갈락토오스, 2,3,4,6-테트라-o-갈로일-D-갈락토오스, 1,3,4,6-테트라-o-갈로일-β-D-갈락토오스 및 1,2,3,4,6-펜타-o-갈로일-β-D-갈락토오스 중에서 선택된 1종 또는 2종 이상을 포함한다.The galloyl galactose used in the present invention is 1-o-galloyl-β-D-galactose, 2-o-galloyl-D-galactose, 3-o-galloyl-D-galactose, 4-o-galloyl -D-galactose, 6-o-galloyl-D-galactose, 1,2-di-o-galloyl-β-D-galactose, 1,3-di-o-galloyl-β-D-galactose, 1,4-di-o-galloyl-β-D-galactose, 1,6-di-o-galloyl-β-D-galactose, 2,3-di-o-galloyl-D-galactose, 2 , 4-di-o-galloyl-D-galactose, 2,6-di-o-galloyl-D-galactose, 3,4-di-o-galloyl-D-galactose, 3,6-di- o-galloyl-D-galactose, 4,6-di-o-galloyl-D-galactose, 1,2,3-tri-o-galoyl-β-D-galactose, 1,2,4-tree -o-galloyl-β-D-galactose, 1,2,6-tri-o-galloyl-β-D-galactose, 1,3,4-tri-o-galloyl-β-D-galactose, 1,3,6-tri-o-galloyl-β-D-galactose, 1,4,6-tri-o-galloyl-β-D-galactose, 2,3,4-tri-o-galloyl -D-galactose, 2,3,6-tri-o-galloyl-D-galactose, 2 , 4,6-tri-o-galloyl-D-galactose, 3,4,6-tri-o-galloyl-D-galactose, 1,2,3,4-tetra-o-galloyl-β- D-galactose, 1,2,3,6-tetra-o-galloyl-β-D-galactose, 1,2,4,6-tetra-o-galloyl-β-D-galactose, 2,3, 4,6-tetra-o-galloyl-D-galactose, 1,3,4,6-tetra-o-galloyl-β-D-galactose and 1,2,3,4,6-penta-o- One or two or more selected from galloyl-β-D-galactose.

본 발명에 따르면, 갈로일갈락토오스를 건조중량에 대하여 0.001-20 중량%, 바람직하게는 0.01-10 중량%를 피부외용연고나 화장료에 첨가한다. 갈로일갈락토오스를 0.001 중량% 이하 사용하는 경우에는 충분한 미백효과를 기대하기 어렵고, 20 중량% 이상 사용하는 경우에는 제형상 및 제품 안정성에 영향을 미치며 과량 사용에 따른 더 이상의 효과증가를 기대할 수도 없고 또한 경제적이지 못하다.According to the present invention, galloyl galactose is added in an amount of 0.001-20% by weight, preferably 0.01-10% by weight, based on the dry weight of the skin external ointment or cosmetic. When using galloylgalactose less than 0.001% by weight it is difficult to expect a sufficient whitening effect, when using more than 20% by weight affects the formulation and product stability and can not be expected to further increase the effect of overuse Not economical

본 발명의 피부미백용 조성물은 상기한 갈로일갈락토오스외에도 통상적인 화장료성분으로서 유화제, 가용화제, 오일, 왁스, 지방산 알콜류, 폴리머, 보습제, 피부보호제, 점증제, 피막형성제, 산화방지제, 금속이온봉쇄제, 자외선차단제, 변색방지제, 비타민류, 수렴제, 향료, 색소, 방부제 등을 화장료의 용도 및 성상에 따라 매우 다양하게 사용될 수 있다.The skin whitening composition of the present invention is a common cosmetic ingredient in addition to the above galloyl galactose as emulsifiers, solubilizers, oils, waxes, fatty alcohols, polymers, moisturizers, skin protectants, thickeners, film forming agents, antioxidants, metal ions Blocking agents, sunscreens, discoloration inhibitors, vitamins, astringents, fragrances, pigments, preservatives and the like can be used in a wide variety of applications and properties of the cosmetic.

본 발명에 따른 피부미백용 조성물은 피부외용 연고나 화장료로서 사용하면 매우 효과적인 것으로 나타났다. 여기서 화장료는 유연화장수, 영양화장수, 영양크림, 맛사지크림, 엣센스, 팩 등을 포함한다.Skin whitening composition according to the present invention was found to be very effective when used as an external skin ointment or cosmetic. Here, the cosmetics include softening cream, nutrient cream, nourishing cream, massage cream, essence, pack and the like.

이하, 본 발명을 실험예 및 실시예에 의거하여 더욱 상세히 설명하고자 한다. 그러나 본 발명의 기술적 범위가 이들로 국한되는 것으로 이해해서는 안된다.Hereinafter, the present invention will be described in more detail based on Experimental Examples and Examples. However, it should not be understood that the technical scope of the present invention is limited thereto.

[제조예][Production example]

갈로일갈락토오스의 분리Isolation of Galloylgalactose

신선한 택칠(Euphorbia Helioscopia L.) 전초(全草) 48.5kg을 잘게 절단하여 80% 아세톤 수용액 50ℓ에 담그어 상온에서 10일간 추출한다. 이 추출물을 감압 농축기로 농축한 다음 거름종이(Whatman No. 1)로 걸러 침전을 제거하고 감압건조하여 악 840g의 추출물을 얻었다. 이것을 sephadex LH-20 칼럼 크로마토그라피를 이용(H2O-MeOH→H2O-아세톤)하여 5개의 분획을 얻었다. 이들 분획중 분획3(335g)을 MCl-gel CHP 20P(H2O→MeOH), sephadex LH-20(H2O→MeOH) 및 Bondapak C18/Poracil B(H2O→MeOH)를 이용하여 1.5g의 2-o-갈로일-D-갈락토오스를 분리하였다.48.5 kg of fresh Echohorbia Helioscopia L. starch is finely chopped and soaked in 50 L of 80% acetone solution and extracted at room temperature for 10 days. The extract was concentrated with a vacuum concentrator, filtered through a filter paper (Whatman No. 1) to remove the precipitate, and dried under reduced pressure to obtain 840 g of the extract. 5 fractions were obtained by using sephadex LH-20 column chromatography (H 2 O-MeOH → H 2 O-acetone). Fraction 3 (335 g) of these fractions was prepared using MCl-gel CHP 20P (H 2 O → MeOH), sephadex LH-20 (H 2 O → MeOH) and Bondapak C18 / Poracil B (H 2 O → MeOH). g of 2-o-galloyl-D-galactose was isolated.

[실험예 1]Experimental Example 1

상기 제조예에서 분리한 갈로일갈락토오스에 대하여 타이로시네이즈 저해효과를 다음과 같이 측정하였다.Tyrosinase inhibitory effect was measured as follows on galloyl galactose isolated in Preparation Example.

효소 타이로시네이즈는 버섯류(mushroom)로 부터 추출한 것으로, 시그마(Sigma)사의 것을 사용하였다. 먼저, 기질인 티로신을 1.5mM의 농도로 소디움 포스페이트 완충액(0.05mol 농도, pH 6.8)에 용액을 만들어 0.3㎖ 분광 광도계 큐벧(Cuvette)에 0.1㎖를 넣고 코팩터(cofactor)인 도파를 0.6mM의 농도로 만들어 0.01㎖씩 첨가한다. 여기에 갈로일갈락토오스를 각각 다른 농도로 첨가하고 각각의 첨가된 갈로일갈락토오스의 부피가 0.1㎖가 되도록 소디움 포스페이트 완충액을 첨가한다. 여기에 타이로시네이즈를 소디움 포스페이트 완충액에 60U/㎖로 제조하여 0.1㎖씩 첨가하여 반응을 진행시킨다. 이때 대조군(Blank)은 타이로시네이즈 대신 완충액만을 0.1㎖씩 첨가한다.Enzyme tyrosinase was extracted from the mushroom (mushroom), Sigma (Sigma) was used. First, a solution of tyrosine, a substrate, was dissolved in sodium phosphate buffer (0.05 mol, pH 6.8) in a concentration of 1.5 mM, and 0.1 ml of 0.3 ml spectrophotometer Cuvette was added, and a cofactor of waveguide was 0.6 mM. Make a concentration and add 0.01 ml each. To this, galloylgalactose is added in different concentrations, and sodium phosphate buffer is added so that the volume of each added galloylgalactose is 0.1 ml. Here, tyrosinase is prepared in sodium phosphate buffer at 60 U / ml, and 0.1 ml of each is added to proceed with the reaction. At this time, the control group (Blank) is added only 0.1ml of buffer instead of tyrosinase.

반응은 분광광도계(Spectrophotometer, Beckman DU-7500)를 이용 37℃에서 진행시키며, 1분마다 475 나노미터에서의 흡광도의 변화를 5분간 측정한다. 여기서 얻어진 반응속도(시간에 따른 흡광도의 변화율, dA/dmim)의 차이로 타이로시네이즈의 저해율을 다음과 같은 식으로 구하였다.The reaction was carried out at 37 ° C. using a spectrophotometer (Beckman DU-7500), and the change in absorbance at 475 nanometers was measured for 5 minutes every minute. The inhibition rate of tyrosinase was determined by the difference of the reaction rate (rate of change in absorbance with time, dA / dmim) obtained as follows.

상기 저해율이 50%가 될 때의 갈로일 갈락토오스의 농도를 IC50(억제농도 50)으로 표현하였으며, 각각의 갈로일갈락토오스에 대한 IC50 값은 하기 표 1 에 나타내었다.The concentration of galloyl galactose when the inhibition rate is 50% was expressed as IC 50 (inhibition concentration 50), the IC 50 value for each galloyl galactose is shown in Table 1 below.

[표 1]TABLE 1

갈로일갈락토오스들의 타이로시네이즈 저해효과(IC50)Tyrosinase Inhibitory Effect of Galoylgalactose (IC50)

상기 표 1 의 결과로부터 갈로일 갈락토오스는 타이로시네이즈의 대한 저해효과가 우수함을 알 수 있다.From the results of Table 1, it can be seen that galloyl galactose has an excellent inhibitory effect on tyrosinase.

[실험예 2]Experimental Example 2

상기 제조예에서 분리한 갈로일갈락토오스를 가지고 쥐의 멜라노마 세포(B-16 마우스 멜라노마 세포)의 배양액에 첨가하여 세포수준에서의 미백효과를 실험하였다(Lotan R., Lotan D. Cancer Res. 40:3345-3350, 1980).The whitening effect at the cellular level was examined by adding galloylgalactose isolated in the above preparation to the culture of rat melanoma cells (B-16 mouse melanoma cells) (Lotan R., Lotan D. Cancer Res. 40: 3345-3350, 1980).

갈로일갈락토오스를 B-16 멜라노마 세포의 배양시 배지에 첨가하여 3일간 배양한 후 세포들을 트립신처리하여 배양 용기로부터 떼어내 원심분리한 후 멜라닌을 추출해 낸다. 이것에 수산화 나트륨 용액(1N 농도) 1㎖를 가하여 10분간 끓여 멜라닌을 녹이고 분광 광도계를 이용, 400 나노미터에서 흡광도를 측정하여 생성된 멜라닌의 양을 단위 세포 수당(106cell)의 흡광도로 나타내는 방법으로 수행하였다. 그 결과는 하기 표 2 에 나타내었다.Galoylgalactose is added to the medium for culturing B-16 melanoma cells and cultured for 3 days, and then the cells are trypsinized, separated from the culture vessel, centrifuged, and melanin is extracted. To this, 1 ml of sodium hydroxide solution (1N concentration) was added, boiled for 10 minutes to dissolve the melanin, and the absorbance was measured at 400 nanometers using a spectrophotometer indicating the amount of melanin produced as the absorbance of a unit cell allowance (10 6 cells). It was performed by the method. The results are shown in Table 2 below.

[표 2]TABLE 2

갈로일갈락토오스의 B-16 멜라노마 세포에 대한 멜라닌 생성 억제효과Inhibitory Effect of Galoylgalactose on Melonogenesis in B-16 Melanoma Cells

*반복수 = 3* Repeat count = 3

상기 표 2 의 결과로부터, 갈로일갈락토오스에는 강력하고 우수한 멜라닌 생성억제능이 있음을 알 수 있다. 이것는 본 발명의 피부미백용 조성물이 기미나 주근깨 개선 또는 피부미백에 매우 유용하게 사용될 수 있음을 입증한다.From the results of Table 2, it can be seen that galloyl galactose has a strong and excellent melanin production inhibitory ability. This demonstrates that the composition for skin whitening of the present invention can be very usefully used for improving skin or freckles or skin whitening.

이와 같이 멜라닌 생성억제 효과가 우수한 갈로일갈락토오스를 가지고 다음과 같은 조성성분 및 조성비에 따라 실시예 1 내지 5의 피부미백용 조성물을 제조하였다.Thus, the composition for skin whitening of Examples 1 to 5 was prepared according to the following composition ingredients and composition ratios with galloyl galactose having an excellent melanin inhibitory effect.

[실시예 1]Example 1

[실시예 2]Example 2

[실시예 3]Example 3

[실시예 4]Example 4

[실시예 5]Example 5

[실험예 3]Experimental Example 3

건강한 남자 20명의 실험대상자의 한쪽팔 상박부에 2cm × 2cm의 크기로 3개씩 2줄의 구멍이 뚫린 알루미늄 호일로 덮은 후 일광조사기(ORIEL, Solar Simulator 1000W)를 이용 50cm거리에서 120mJ/㎠의 광량을 조사하였다. 조사전 에탄올 70% 수용액으로 조사부위를 잘 세척하였다. 자외선 조사후 조사부위 한쪽줄 3곳에는 실시예 1, 4 및 5를, 다른 한 줄에는 각각의 기제를 1일 2회, 4주간 도포하였다. 4주 후에는 육안으로 색소침착의 정도를 대조군(기제도포)과 비교하여 판정하였으며, 판정 기준은 현저한 저해효과, 약간의 저해효과, 저해효과 없음의 3단계 평가로 하였다. 그 결과는 다음 표 3 과 같다.20m healthy male subjects were covered with 2 foils of aluminum foil with 3 lines of 2cm x 2cm in the upper arm of one arm and 120mJ / ㎠ light at 50cm distance using ORIEL, Solar Simulator 1000W. Was investigated. The irradiation site was washed well with 70% aqueous ethanol solution before irradiation. After UV irradiation, Examples 1, 4, and 5 were applied to one row of three irradiation sites, and each base was applied twice a day for four weeks to the other row. Four weeks later, the degree of pigmentation was visually determined by comparison with the control group (gigi coating), and the criterion was a three-step evaluation of remarkable inhibitory effect, slight inhibitory effect, and no inhibitory effect. The results are shown in Table 3 below.

[표 3]TABLE 3

색소침착 저해효과(명)Pigmentation inhibitory effect (persons)

상기 표 3 의 결과로부터 알 수 있듯이 본 발명에 의한 실시예 1, 4 및 5는 모두 최소 14 명 이상이 약간의 색소침착저해 이상의 효과를 나타냄으로 본 발명에 의한 피부미백용 조성물이 매우 우수한 색소침착 저해효과가 있음을 입증한다.As can be seen from the results of Table 3, Examples 1, 4, and 5 according to the present invention all have at least 14 or more pigmentation inhibitory effects. Demonstrates an inhibitory effect.

Claims (6)

갈로일갈락토오스를 건조중량에 대하여 0.001-20 중량% 함유하는 것을 특징으로 하는 피부미백용 조성물.A skin whitening composition comprising galloyl galactose in an amount of 0.001-20% by weight based on dry weight. 제 1 항에 있어서, 갈로일갈락토오스가 1-o-갈로일-β-D-갈락토오스, 2-o-갈로일-D-갈락토오스, 3-o-갈로일-D-갈락토오스, 4-o-갈로일-D-갈락토오스, 6-o-갈로일-D-갈락토오스, 1,2-디-o-갈로일-β-D-갈락토오스, 1,3-디-o-갈로일-β-D-갈락토오스, 1,4-디-o-갈로일-β-D-갈락토오스, 1,6-디-o-갈로일-β-D-갈락토오스, 2,3-디-o-갈로일-D-갈락토오스, 2,4-디-o-갈로일-D-갈락토오스, 2,6-디-o-갈로일-D-갈락토오스, 3,4-디-o-갈로일-D-갈락토오스, 3,6-디-o-갈로일-D-갈락토오스, 4,6-디-o-갈로일-D-갈락토오스, 1,2,3-트리-o-갈로일-β-D-갈락토오스, 1,2,4-트리-o-갈로일-β-D-갈락토오스, 1,2,6-트리-o-갈로일-β-D-갈락토오스, 1,3,4-트리-o-갈로일-β-D-갈락토오스, 1,3,6-트리-o-갈로일-β-D-갈락토오스, 1,4,6-트리-o-갈로일-β-D-갈락토오스, 2,3,4-트리-o-갈로일-D-갈락토오스, 2,3,6-트리-o-갈로일-D-갈락토오스, 2,4,6-트리-o-갈로일-D-갈락토오스, 3,4,6-트리-o-갈로일-D-갈락토오스, 1,2,3,4-테트라-o-갈로일-β-D-갈락토오스, 1,2,3,6-테트라-o-갈로일-β-D-갈락토오스, 1,2,4,6-테트라-o-갈로일-β-D-갈락토오스, 2,3,4,6-테트라-o-갈로일-D-갈락토오스, 1,3,4,6-테트라-o-갈로일-β-D-갈락토오스 및 1,2,3,4,6-펜타-o-갈로일-β-D-갈락토오스 중에서 선택된 1종 또는 2종 이상임을 특징으로 하는 피부미백용 조성물.The method of claim 1 wherein the galloylgalactose is 1-o-galloyl-β-D-galactose, 2-o-galloyl-D-galactose, 3-o-galloyl-D-galactose, 4-o-gallo Yl-D-galactose, 6-o-galloyl-D-galactose, 1,2-di-o-galloyl-β-D-galactose, 1,3-di-o-galloyl-β-D-galactose , 1,4-di-o-galloyl-β-D-galactose, 1,6-di-o-galoyl-β-D-galactose, 2,3-di-o-galloyl-D-galactose, 2,4-di-o-galloyl-D-galactose, 2,6-di-o-galoyl-D-galactose, 3,4-di-o-galloyl-D-galactose, 3,6-di -o-galloyl-D-galactose, 4,6-di-o-galloyl-D-galactose, 1,2,3-tri-o-galoyl-β-D-galactose, 1,2,4- Tri-o-galloyl-β-D-galactose, 1,2,6-tri-o-galloyl-β-D-galactose, 1,3,4-tri-o-galloyl-β-D-galactose , 1,3,6-tri-o-galloyl-β-D-galactose, 1,4,6-tri-o-galoyl-β-D-galactose, 2,3,4-tri-o-gallo Yl-D-galactose, 2,3,6-tri-o-galloyl-D-galactose, 2,4,6- Li-o-galloyl-D-galactose, 3,4,6-tri-o-galloyl-D-galactose, 1,2,3,4-tetra-o-galloyl-β-D-galactose, 1 , 2,3,6-tetra-o-galloyl-β-D-galactose, 1,2,4,6-tetra-o-galloyl-β-D-galactose, 2,3,4,6-tetra -o-galloyl-D-galactose, 1,3,4,6-tetra-o-galoyl-β-D-galactose and 1,2,3,4,6-penta-o-galloyl-β- A composition for skin whitening, characterized in that one or two or more selected from D-galactose. 제 1 항에 있어서, 갈로일갈락토오스를 0.01-10 중량% 함유하는 것을 특징으로 하는 피부미백용 조성물.The skin whitening composition according to claim 1, which contains 0.01-10% by weight of galloylgalactose. 제 1 항에 있어서, 화장료용 조성물인 것을 특징으로 하는 피부미백용 조성물.The composition for skin whitening according to claim 1, which is a cosmetic composition. 제 1 항에 있어서, 피부외용연고용 조성물인 것을 특징으로 하는 피부미백용 조성물.The skin whitening composition according to claim 1, which is a composition for external application of the skin. 제 4 항에 있어서, 화장료가 유연화장수, 영양화장수, 영양크림, 맛사지크림, 엣센스 또는 팩임을 특징으로 하는 피부미백용 조성물.5. The composition for skin whitening according to claim 4, wherein the cosmetic is a softening cream, a nutrient cream, a nourishing cream, a massage cream, an essence or a pack.
KR1019960052294A 1996-11-06 1996-11-06 Skin whitening composition containing galloylgalactose KR19980034291A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019960052294A KR19980034291A (en) 1996-11-06 1996-11-06 Skin whitening composition containing galloylgalactose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019960052294A KR19980034291A (en) 1996-11-06 1996-11-06 Skin whitening composition containing galloylgalactose

Publications (1)

Publication Number Publication Date
KR19980034291A true KR19980034291A (en) 1998-08-05

Family

ID=66519958

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960052294A KR19980034291A (en) 1996-11-06 1996-11-06 Skin whitening composition containing galloylgalactose

Country Status (1)

Country Link
KR (1) KR19980034291A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990038402A (en) * 1997-11-05 1999-06-05 성재갑 Cosmetic composition for preventing skin aging
KR20030037993A (en) * 2001-11-08 2003-05-16 주식회사 엘지생활건강 Composition for skin whitening containing 1-desgalloyleugeniin

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02134309A (en) * 1988-11-16 1990-05-23 Kikkoman Corp Beautifying and whitening cosmetic
US4975272A (en) * 1976-11-10 1990-12-04 Voyt Walter F Method of and composition for the prevention of solar radiation exposure-induced formation of carcinogenic skin lipid degradation products
JPH03178916A (en) * 1989-12-06 1991-08-02 Shiseido Co Ltd Skin external agent
JPH03193713A (en) * 1989-12-25 1991-08-23 Maremitsu Izumitani Tannin-containing composition
JPH03258711A (en) * 1990-03-06 1991-11-19 Sansho Seiyaku Co Ltd Skin-whitening agent for external use
JPH06239716A (en) * 1993-02-17 1994-08-30 Kanebo Ltd Composition comprising polyphenolic compound

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975272A (en) * 1976-11-10 1990-12-04 Voyt Walter F Method of and composition for the prevention of solar radiation exposure-induced formation of carcinogenic skin lipid degradation products
JPH02134309A (en) * 1988-11-16 1990-05-23 Kikkoman Corp Beautifying and whitening cosmetic
JPH03178916A (en) * 1989-12-06 1991-08-02 Shiseido Co Ltd Skin external agent
JPH03193713A (en) * 1989-12-25 1991-08-23 Maremitsu Izumitani Tannin-containing composition
JPH03258711A (en) * 1990-03-06 1991-11-19 Sansho Seiyaku Co Ltd Skin-whitening agent for external use
JPH06239716A (en) * 1993-02-17 1994-08-30 Kanebo Ltd Composition comprising polyphenolic compound

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990038402A (en) * 1997-11-05 1999-06-05 성재갑 Cosmetic composition for preventing skin aging
KR20030037993A (en) * 2001-11-08 2003-05-16 주식회사 엘지생활건강 Composition for skin whitening containing 1-desgalloyleugeniin

Similar Documents

Publication Publication Date Title
KR20080001791A (en) Skin anti-wrinkle cosmetics composition containing forsythiae fruit extract
KR101975951B1 (en) Manufacturing Method of Japanese Rose Flower Extract and Rose Flower Extract for Whitening Cosmetic Preparations containing these Extracts
KR20020060219A (en) Skin texture-improving agents
KR101367306B1 (en) Whitening or moisturizing cosmetic composition comprising tetradecanol extracted from dendropanax morbifera lev
KR100190993B1 (en) Water soluble fraction extracts of asparagus cochinchinensis having improved skin whitening defects by removing darkening components and a composition for improving freckles and skin whitening containing thereof
KR100190992B1 (en) A skin whitening composition containing extracts of asparagus cochinchinensis and tyrosinase inhibitor
JPH1029927A (en) Antiaging agent
KR100496850B1 (en) The Skin Lightening Cosmetic Composition Containing Extract Of Gardenia
KR100466379B1 (en) Composition for skin whitening
KR19980050697A (en) Green mushroom extract and skin cosmetic containing same
KR102373899B1 (en) Multifunctional cosmetic composition containing complex natural extracts effective for skin wrinkle improvement, whitening, cell regeneration, and wound healing as an active ingredient
KR20190081627A (en) Cosmetic composition for whitening and anti-wrinkle containing Batillus cornutus derived peptide powder
JPH0987164A (en) Skin preparation for external use
KR100416400B1 (en) Composition containing extracts from dried roots of Trichosantes kirilowii maxim for external application and skin-whitening and process for preparation thereof
KR19980034291A (en) Skin whitening composition containing galloylgalactose
KR20010000390A (en) Skin Improvement Composition Including Anti-Aging and Anti-Acne with Kimchi Extract
KR19980034292A (en) Skin whitening composition containing galloylquinic acid
KR19990081226A (en) Skin cosmetic using natural mushrooms
KR100542446B1 (en) A cosmetic composition containing an extract of capsosiphon fulvescens
KR100453217B1 (en) Skin whitener
KR19980027092A (en) Skin whitening composition containing antibacterial plant extract
KR19980034290A (en) Skin whitening composition containing gallic acid derivative
KR19980034293A (en) Skin whitening composition containing galloyl simic acid
KR19980034289A (en) Skin whitening composition containing galloyl allose
KR100467501B1 (en) A cosmetic composite

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E601 Decision to refuse application